Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,466,459
in 2 filings

Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +15,000 $37.46 $562K 353,569
2022-03-10 BIENAIME JEAN JACQUES Chief Executive Officer Sale −15,000 $77.57 $1.2M 338,569
2022-03-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −15,000 100,000
2022-03-08 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award +34,780 338,569
2022-03-08 FUCHS HENRY J President, Worldwide R&D Grant or award +12,840 119,323
2022-03-08 Davis George Eric EVP, General Counsel Grant or award +9,370 67,960
2022-03-08 Ajer Jeffrey Robert EVP, Chief Commercial Officer Grant or award +9,370 65,223
2022-02-28 Slamon Dennis Director Sale −5,815 $78.33 $455K 22,220
2022-02-28 Slamon Dennis Director Sale −45 $78.34 $4K 22,175
2022-02-28 Slamon Dennis Director Sale −214 $78.35 $17K 21,961
2022-02-28 Slamon Dennis Director Sale −100 $78.35 $8K 21,861
2022-02-28 Slamon Dennis Director Sale −122 $78.36 $10K 21,739
2022-02-28 Slamon Dennis Director Sale −100 $78.37 $8K 21,639
2022-02-25 HERON ELAINE J Director Exercise or conversion +8,500 $37.46 $318K 80,588
2022-02-25 HERON ELAINE J Director Exercise or conversion · Stock Option (Right to buy Common Stock) −8,500 0
2022-02-03 Mueller Brian EVP, Chief Financial Officer Shares withheld for taxes −1,072 $87.77 $94K 29,709
2022-01-14 LAWLIS V BRYAN Director Exercise or conversion +4,250 $37.46 $159K 28,220
2022-01-14 LAWLIS V BRYAN Director Sale −4,250 $87.61 $372K 23,970
2022-01-14 LAWLIS V BRYAN Director Exercise or conversion · Stock Option (Right to buy Common Stock) −4,250 4,250
2022-01-13 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +5,000 $37.46 $187K 308,789

Page 26 of 36 · 707 trades